MAPT and Alzheimer disease: Their studies involved 46 cases of patients clinically diagnosed with AD, among which 96% showed tau phosphorylation in the cervical spinal segment, 69% showed tau phosphorylation in the thoracic spinal segment, 65% showed tau phosphorylation in the lumbar spinal segment, and 53% showed tau phosphorylation in the sacral spinal segment [18].